从突变到管理:通过组合疗法推进朗格汉斯细胞细胞症治疗

Akiva Diamond1

  • 1Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

PubMed
概括

将MAPK通路抑制剂与化疗相结合,显示出治疗复发性朗格汉斯细胞囊细胞瘤 (LCH) 的前景. 这种方法可能为患有难以治疗的LCH的患者提供更具侵略性,潜在的治愈策略.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K